SPIA
GTHX

Steward Partners Investment Advisory’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

Steward Partners Investment Advisory’s Portfolio GTHX Stock Details GTHX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-3,000
Closed -$7.47K – 3459
2023
Q2 		$7.47K Buy
+3,000
New +$8.2K ﹤0.01% 2664
2021
Q2 		– Sell
-1,000
Closed -$24.1K – 7468
2021
Q1 		$24.1K Buy
+1,000
New +$23.2K ﹤0.01% 2385

Other funds holding GTHX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Steward Partners Investment Advisory's GTHX Position: Q3 2023 in Review

Steward Partners Investment Advisory sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q3 2023, closing a stake of 3,000 shares — an estimated $7.47K sold.

Steward Partners Investment Advisory first reported a position in GTHX in Q1 2021 and held it in 2 quarters. The position peaked at $24.1K in Q1 2021. 72 funds tracked by Wall St. Rank hold GTHX as of Q3 2023.

  • Steward Partners Investment Advisory reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Steward Partners Investment Advisory sold 3,000 G1 Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $7.47K.
  • Steward Partners Investment Advisory first reported a position in G1 Therapeutics, Inc. Common Stock in Q1 2021 and held it in 2 quarters.
  • Steward Partners Investment Advisory's G1 Therapeutics, Inc. Common Stock position peaked at $24.1K in Q1 2021.
  • 72 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Steward Partners Investment Advisory's 13F filing for Q3 2023, filed 13 Nov 2023.